DEUTSCHE BANK AG\

Bank

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 948046 FRANKFURT AM MAIN, 2M

Back to BCRX Full portfolio

Position in BCRX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$5,633,610

-$2,185,802 QoQ

Shares Held

563,361

-31.4% QoQ

Ownership

0.220%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#58

of 316 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $1,001,919,079 across 44 Drug Manufacturers - Specialty & Generic names. BCRX ranks #15 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	5,851,737	$420,505,812
2	VTRS	Viatris Inc	7,891,271	$125,313,379
3	UTHR	UNITED THERAPEUTICS Corp	195,269	$105,802,598
4	TEVA	Teva Pharmaceutical Industries Ltd	3,037,225	$102,901,179
5	NBIX	Neurocrine Biosciences Inc	334,650	$56,401,907
6	LNTH	Lantheus Holdings, Inc.	248,743	$27,595,547
7	ANIP	Ani Pharmaceuticals Inc	323,443	$26,774,610
8	KNSA	Kiniksa Pharmaceuticals International, plc	387,606	$24,787,402

All Filings in BCRX

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,633,610	563,361	-31.4%	Shares	Defined	2026-08-07
2026-03-31	$7,819,412	821,367	+67.3%	Shares	Defined	2026-05-06
2025-12-31	$3,830,470	491,086	-54.1%	Shares	Defined	2026-02-11
2025-09-30	$8,113,822	1,069,015	+129.5%	Shares	Defined	2025-11-13
2025-06-30	$4,173,844	465,831	-6.1%	Shares	Defined	2025-08-12
2025-03-31	$3,720,315	496,042	-4.5%	Shares	Defined	2025-05-09
2024-12-31	$3,904,511	519,217	+12.7%	Shares	Defined	2025-06-30
2024-09-30	$3,500,027	460,530	+6.6%	Shares	Defined	2025-06-26
2024-06-30	$2,669,722	431,994	-42.3%	Shares	Defined	2025-06-12
2024-03-31	$3,803,872	748,794	-27.0%	Shares	Defined	2025-06-02
2023-12-31	$6,145,989	1,026,042	+929.0%	Shares	Defined	2024-02-14
2023-09-30	$705,953	99,711	+11.8%	Shares	Defined	2023-11-24
2023-06-30	$628,052	89,212	-36.7%	Shares	Defined	2023-08-14
2023-03-31	$1,175,572	140,956	+29.3%	Shares	Defined	2023-05-15
2022-12-31	$1,251,549	109,020	+26.4%	Shares	Defined	2023-02-13
2022-09-30	$1,086,560	86,235	-16.4%	Shares	Defined	2022-11-14
2022-06-30	$1,091,833	103,198	-7.3%	Shares	Defined	2022-08-11
2022-03-31	$1,809,525	111,287	-8.5%	Shares	Defined	2022-05-13
2021-12-31	$1,684,367	121,615	-42.7%	Shares	Defined	2022-02-16
2021-09-30	$3,049,298	212,199	+49.5%	Shares	Defined	2021-11-04
2021-06-30	$2,243,326	141,893	+9.7%	Shares	Defined	2021-08-11
2021-03-31	$1,315,194	129,321	-9.6%	Shares	Defined	2021-05-13
2020-12-31	$1,065,929	143,078	+29.5%	Shares	Defined	2021-02-16
2020-09-30	$380,102	110,495	+1.5%	Shares	Defined	2020-11-12
2020-06-30	$518,300	108,887	-95.3%	Shares	Defined	2020-08-13
2020-03-31	$4,640,918	2,320,459	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.